Société Savara Inc Nyse
Actions
US5763141083
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Matthew Pauls
CEO | Chief Executive Officer | 53 | 27/04/17 |
David Lowrance
DFI | Director of Finance/CFO | 56 | 27/04/17 |
Robert M. Lutz
COO | Chief Operating Officer | 55 | 13/02/23 |
Raymond Pratt
CTO | Chief Tech/Sci/R&D Officer | 73 | 10/11/22 |
Anne Erickson
IRC | Investor Relations Contact | - | 01/10/18 |
Charles LaPree
LAW | General Counsel | - | 01/08/21 |
Kate McCabe
LAW | General Counsel | - | 01/03/18 |
Scott Wilhoit
PRN | Corporate Officer/Principal | 61 | 09/01/23 |
Peter M. Clarke
PRN | Corporate Officer/Principal | 64 | 01/09/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
David Ramsay
BRD | Director/Board Member | 59 | 27/04/17 |
Richard Hawkins
BRD | Director/Board Member | 75 | 01/10/10 |
Nevan Elam
BRD | Director/Board Member | 56 | 01/02/09 |
Ricky Sun
BRD | Director/Board Member | 50 | 24/12/19 |
Joseph McCracken
BRD | Director/Board Member | 71 | 27/04/17 |
Matthew Pauls
CEO | Chief Executive Officer | 53 | 27/04/17 |
Director/Board Member | 64 | 03/12/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 138 188 891 | 130 399 382 ( 94,36 %) | 0 | 94,36 % |
Coordonnées société
Savara, Inc.
1717 Langhorne Newtown Road Suite 302
19047, Langhorne
+(512) 614-1848
http://www.savarapharma.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+5,05% | 109 Md | |
+11,62% | 105 Md | |
-0,32% | 22,25 Md | |
-11,81% | 22,09 Md | |
-7,91% | 18,68 Md | |
-38,36% | 17,58 Md | |
-9,95% | 16,85 Md | |
+4,55% | 13,76 Md | |
+36,36% | 12,46 Md |
- Bourse
- Actions
- Action SVRA
- Action
- Société Savara Inc